Safety of Recombinant VSV-Ebola Virus Vaccine Vector in Pigs

被引：25
|
作者：
de Wit, Emmie [1 ]
Marzi, Andrea [1 ]
Bushmaker, Trenton [1 ]
Brining, Doug [1 ]
Scott, Dana [1 ]
Richt, Juergen A. [2 ]
Geisbert, Thomas W. [3 ]
Feldmann, Heinz [1 ,4 ]
机构：
[1] NIAID, Hamilton, MT 59840 USA
[2] Kansas State Univ, Coll Vet Med, Manhattan, KS 66506 USA
[3] Univ Texas Med Branch, Galveston, TX 77555 USA
[4] Univ Manitoba, Winnipeg, MB, Canada
来源：
EMERGING INFECTIOUS DISEASES | 2015年 / 21卷 / 04期
基金：
美国国家卫生研究院;
关键词：
VESICULAR STOMATITIS-VIRUS; NONHUMAN-PRIMATES; GLYCOPROTEINS;
D O I：
10.3201/eid2104.142012
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
The ongoing Ebola outbreak in West Africa has resulted in fast-track development of vaccine candidates. We tested a vesicular stomatitis virus vector expressing Ebola virus glycoprotein for safety in pigs. Inoculation did not cause disease and vaccine virus shedding was minimal, which indicated that the vaccine virus does not pose a risk of dissemination in pigs.
引用
收藏
页码：702 / 704
页数：3
相关论文
共 50 条
  • [41] Inducible Vesicular Stomatitis Virus (VSV) L Cell Line for Packaging of Recombinant VSV
    Seong-Karp Hong
    Yong-Tae Jung
    Seung-Won Park
    Soon-Young Paik
    Virus Genes, 2005, 31 : 195 - 201
  • [42] Recombinant Antibodies to the Ebola Virus Glycoprotein
    Panina, A. A.
    Dementieva, I. G.
    Aliev, T. K.
    Toporova, V. A.
    Balabashin, D. S.
    Bokov, M. N.
    Pozdnyakova, L. P.
    Shemchukova, O. B.
    Dolgikh, D. A.
    Sveshnikov, P. G.
    Kirpichnikov, M. P.
    ACTA NATURAE, 2017, 9 (04): : 84 - 91
  • [43] Current status of recombinant duck enteritis virus vector vaccine research
    Jia, Wen-Feng
    Wang, An-Ping
    Wu, Zhi
    Lei, Xin-Nuo
    Cheng, Yu-Ting
    Zhu, Shan-Yuan
    FRONTIERS IN VETERINARY SCIENCE, 2025, 12
  • [44] Recombinant vesicular stomatitis virus as an HIV-1 vaccine vector
    Clarke, David K.
    Cooper, David
    Egan, Michael A.
    Hendry, R. Michael
    Parks, Christopher L.
    Udem, Stephen A.
    SPRINGER SEMINARS IN IMMUNOPATHOLOGY, 2006, 28 (03): : 239 - 253
  • [45] Assessment of protective immunity conferred by recombinant vaccinia viruses to guinea pigs challenged with Ebola virus
    Gilligan, KJ
    Geisbert, JB
    Jahrling, PB
    Anderson, K
    VACCINES 97 - MOLECULAR APPROACHES TO THE CONTROL OF INFECTIOUS DISEASES, 1997, : 87 - 92
  • [46] Ebola vaccine trials: progress in vaccine safety and immunogenicity
    Matz, Keesha M.
    Marzi, Andrea
    Feldmann, Heinz
    EXPERT REVIEW OF VACCINES, 2019, 18 (12) : 1229 - 1242
  • [47] Recombinant vesicular stomatitis virus as an HIV-1 vaccine vector
    David K. Clarke
    David Cooper
    Michael A. Egan
    R. Michael Hendry
    Christopher L. Parks
    Stephen A. Udem
    Springer Seminars in Immunopathology, 2006, 28 : 239 - 253
  • [48] Recombinant Semliki Forest virus vector exhibits potential for avian virus vaccine development
    Phenix, KV
    Wark, K
    Luke, CJ
    Skinner, MA
    Smyth, JA
    Mawhinney, KA
    Todd, D
    VACCINE, 2001, 19 (23-24) : 3116 - 3123
  • [49] Ebola virus: from discovery to vaccine
    Heinz Feldmann
    Steven Jones
    Hans-Dieter Klenk
    Hans-Joachim Schnittler
    Nature Reviews Immunology, 2003, 3 : 677 - 685
  • [50] Current Ebola Virus Vaccine Progress
    Andrea Marzi
    Chad E. Mire
    BioDrugs, 2019, 33 : 9 - 14
12345